Company: BGLC
Filing Date: 2025-11-13
Form Type: 8-K
Source: 0001477932-25-008137
Chunk: 1

Company: BioNexus Gene Lab Corp
Filing Date: 2025-11-13
Form: 8-K
Item: Item 7.01
Chunk 1
---
Item 7.01. Regulation FD Disclosure.

On November 10, 2025, the Company issued a press release announcing its entry into the Agreement and the establishment of the ATM Program. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information contained in this Item 7.01 (including Exhibit 99.1) is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01. Financial Statement and Exhibits.